SCHEMBL8303584

SCHEMBL8303584

FC(F)(F)c1ccc2c(c1)N(c1cc(CS)ccc1Cl)CCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
ADRA1B P35368 1/20 0.36
KDM4E B2RXH2 1/20 0.35
RORC P51449 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8521572 0.77 TMEM97 (0.42) ALDH1A1HDAC1HDAC8HDAC6MEN1
SCHEMBL7101845 0.76 HDAC8 (0.35) ALDH1A1HDAC3HDAC1HDAC7HDAC2
SCHEMBL7101931 0.70 KMT2A (0.41) KMT2AL3MBTL1KDM4ERORCOPRM1
SCHEMBL11988645 0.69 NOTUM (0.42) ALDH1A1HDAC3HDAC1HDAC7HDAC2
SCHEMBL6491751 0.68 JUN (0.37) ALDH1A1HDAC3HDAC1HDAC7HDAC2
SCHEMBL13986666 0.67 NPC1 (0.43) ALDH1A1HDAC3HDAC1HDAC7HDAC2
SCHEMBL7262692 0.67 CNR2 (0.42) ALDH1A1HDAC3HDAC1HDAC7HDAC2
SCHEMBL11989094 0.66 HRH3 (0.48) ALDH1A1HDAC3HDAC1HDAC7HDAC2
SCHEMBL5466561 0.65 CPT2 (0.52) ALDH1A1MEN1TSHRKMT2AATM
SCHEMBL22719567 0.64 SCN9A (0.48) ALDH1A1HDAC6L3MBTL1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0925300-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-06-30 EP claimed
EP-0925300-A4 1999-06-30 EP claimed
WO-1997030054-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1997-08-21 WO claimed